The bone thinning drug raloxifene is as effective as the breast cancer prevention drug tamoxifen in reducing breast cancer risk for postmenopausal women already at an increased risk of developing the disease and is less likely to cause serious complications, according to initial results of a National Cancer Institute-sponsored study released on Monday, the Washington Post reports (Stein, Washington Post, 4/18)... click link for more info.

http://www.medicalnewstoday.com/medicalnew...5&nfid;=rssfeeds